CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today ...
GALWAY, Ireland--(BUSINESS WIRE)--Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, proudly announces FDA clearance for the ...
Amid growing interest in interventional stroke treatments, some questions have recently emerged regarding the use of various catheters for aspiration thrombectomy that aren’t approved for that purpose ...
The newly granted patent outlines a conceptual design for aspiration catheters that could revolutionize thrombus removal in vascular systems. Key conceptual features include: Slim Profile and ...
Biologic Therapies has announced it has received FDA clearance for its new bone marrow aspiration catheter, according to a news release. The Bio-MAC bone marrow aspiration catheter is designed to ...
Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...
Rockville, MD - The FDA has granted marketing clearance for the Xtract thrombus aspiration catheter, the device manufacturer, Lumen Biomedical (Rochester, MN), has announced. The catheter can remove ...
MIAMI & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation ...
CAT RX established high rates of blood clot removal, blood flow restoration and myocardial perfusion normalization No serious adverse events associated with the use of sustained power aspiration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results